Akhapkin Roman Vitalyevich

PHENOTROPIL

Antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of infectious diseases of the upper divisions of respiratory tract; pharmaceutical preparations for the treatment of infectious diseases of the lower divisions of respiratory tract; pharmaceutical preparations for the treatment of infectious diseases of the skin and soft tissue; pharmaceutical preparations for the treatment of infectious diseases of the urogenital tract; pharmaceutical preparations for the treatment of Lyme disease; pharmaceutical preparations for the treatment of stomach diseases associated with Helicobacter Pylori; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical preparations for use in urology; and pharmaceutical products for treating respiratory diseases and asthma;Color is not claimed as a feature of the mark.;

PHENOTROPIL

Pharmaceutical preparations for the treatment of mental and neural illness or disorder, illness or disorder connected with stroke; pharmaceutical preparations for the treatment of illness or disorder connected with dysfunctional immunity; with loss of organism resistance to rugged environment; with psychoemotional stress and stresses of different etiology; pharmaceutical preparations for the treatment of illness connected with hearing and visual disorder; pharmaceutical preparations for the treatment of illness connected with peripheric circulation disorder; pharmaceutical preparations for the treatment of sexual disorder and illness connected with the aforesaid; pharmaceutical preparations for the treatment of alcohol, drug and other addictive substances dependence; pharmaceutical preparations for the treatment of social maladjustment; pharmaceutical preparations for the treatment of obesity of different etiology; pharmaceutical preparations for treatment of those exhibiting mental impairment, defective memory, detraction and mental retardation; pharmaceutical preparations meant for increasing organism resistance to infectious and virus diseases; pharmaceutical preparations meant for increasing mental and physical work capacity in extreme conditions of professional activity; pharmaceutical preparations meant for prevention and treatment of hypoxia, illness and disorder connected with hypoxia;Color is not claimed as a feature of the mark.;